TYP 10.5% 2.1¢ tryptamine therapeutics limited

Codiak ($800mil market capitalisation), page-52

  1. 166 Posts.
    lightbulb Created with Sketch. 267
    That's a pretty old report, nothing recent. It's essentially just "don't take treatments that are not approved by the FDA". It doesn't say anything about exosomes being bad, just that there are no exosome products currently approved and thus these clinics marketing these claims are frauds. So it sounds like there was some kind of scam going on, and they made this announcement as a response.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.002(10.5%)
Mkt cap ! $22.87M
Open High Low Value Volume
1.9¢ 2.1¢ 1.9¢ $27.87K 1.464M

Buyers (Bids)

No. Vol. Price($)
2 527780 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 613000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.